TOPIX 500
2.122,61
PKT
-5,34
PKT
-0,25
%
Werbung
Analysen zu TOPIX 500-Werten
Datum | Rating | Analyst | |
---|---|---|---|
27.01.06 | Sharp kaufen | DZ-Bank | |
24.01.06 | Honda Motor equal-weight | Morgan Stanley | |
23.01.06 | Astellas Pharma in-line | Goldman Sachs | |
24.01.06 | Astellas Pharma In-Line | Goldman Sachs | |
19.01.06 | Sharp kaufen | Frankfurter Tagesdienst | |
19.01.06 | Sharp kaufen | Asia Investor | |
13.01.06 | Sharp kaufen | DZ-Bank | |
09.01.06 | Astellas Pharma underperform | Credit Suisse First Boston | |
06.01.06 | Sharp kaufen | DZ-Bank | |
27.12.05 | Bridgestone halten | Pacific Continental Sec. | |
23.12.05 | Sharp kaufen | DZ-Bank | |
16.12.05 | Sharp | DZ-Bank | |
09.12.05 | Sharp | DZ-Bank | |
08.12.05 | Bridgestone | Wirtschaftswoche | |
02.12.05 | Sharp | DZ-Bank | |
01.12.05 | NEC kaufen | Asia Investor | |
28.11.05 | Sharp | DZ-Bank | |
23.11.05 | Honda Motor kaufen | Asia Investor | |
22.11.05 | Astellas Pharma neutral | UBS | |
18.11.05 | Sharp | DZ-Bank | |
28.11.05 | Astellas Pharma | Biotech-Report | |
15.11.05 | Sharp | DZ-Bank | |
10.11.05 | Honda Motor overweight | Prudential Financial | |
11.11.05 | Honda Motor overweight | Prudential Financial | |
09.11.05 | Bridgestone kaufen | Asia Investor | |
08.11.05 | Honda Motor equal-weight | Morgan Stanley | |
04.11.05 | Bridgestone equal-weight | Morgan Stanley | |
03.11.05 | Mitsubishi kaufen | Asia Investor | |
28.10.05 | Honda Motor equal-weight | Morgan Stanley | |
19.10.05 | Astellas Pharma underperform | Credit Suisse First Boston | |
13.10.05 | Astellas Pharma neutral | UBS | |
11.10.05 | Astellas Pharma peer perform | Bear Stearns | |
11.10.05 | Astellas Pharma Peer Perform | Bear Stearns | |
30.09.05 | Honda Motor Neutral | Credit Suisse First Boston | |
23.09.05 | Astellas Pharma outperform | Bear Stearns | |
15.09.05 | Astellas Pharma peer perform | Thomas Weisel Partners | |
15.09.05 | Astellas Pharma buy | Merrill Lynch | |
07.09.05 | Renesas Electronics neutral | Asia Investor | |
31.08.05 | Astellas Pharma | Global Biotech Investing | |
26.08.05 | Astellas Pharma overweight | Morgan Stanley |